DUE DILIGENCE REPORT: Creative Edge Nutrition Spins off Marijuana Business - BrokerBank Securities, Inc.

NEW YORK, Sept. 25, 2015 PR Newswire – Creative Edge Nutrition, Inc. (OTCBB: FITX) closed at $.0058, up 39.5% in yesterday's session. The rise in price came on the heels of a recent price increase from $.0028 that started on September 17th. Trading volume was up from a daily average of 9 million shares to 103 million shares.

Our due diligence will show investors in Creative Edge Nutrition, Inc. the information they need. Get our brief report at the link below.

http://bit.ly/-FITX_Due_Diligence

Copy and paste to browser may be required.

About Creative Edge Nutrition, Inc.

Creative Edge Nutrition, Inc. is a holding company and a Nutritional Supplement Company focused on developing supplements and energy drinks. The company offers capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. CEN Biotech, Inc. was established in 2013 as a partially owned subsidiary of Creative Edge Nutrition for the sole purpose of supplying the Canadian public with pharmaceutical-grade medical cannabis under the newly established Marihuana for Medical Purposes Regulations (MMPR).

Forward-Looking Disclaimer   

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.  

Compliance Procedure   

Content is researched, written and reviewed on a best-effort basis. This release and report was prepared for informational purposes only. Affiliated parties involved with producing and issuing this release have not been compensated in any form by any source. A full disclaimer can be found by viewing due diligence. We are only human and may make mistakes. If you notice any errors or omissions, please notify us below.

A full disclaimer can be found by viewing the full analyst report.  

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE BrokerBank Securities, Inc.

Related Links

http://www.brokerbanksecurities.com